Sales Of Small Bowel Capsules Are Expected To Rise At A CAGR Of 8% By The End Of 2027

Healthcare

The global capsule endoscope systems market currently accounts for a valuation of US$ 465 million and is expected to reach US$ 695 million by the end of 2027. This is because global demand for capsule endoscope systems is predicted to increase at a high-value CAGR of 8.3% from 2022 to 2027.

Sales of small bowel capsules are expected to rise at a CAGR of 8% over the forecast period. Growing usage of small bowel capsules by medical and healthcare professionals for speedier and more precise diagnosis of chronic diseases is driving market demand considerably.

Request Sample

Competitive Landscape

Key companies are focusing on broadening their product lines and growing their market share. The increased demand for capsule-based endoscopes and endoscopic systems for different screening and diagnostic procedures has created intense competition among the existing providers. Furthermore, the competition is getting more intense due to technological advancements in the field of endoscopy made by key players.

For instance :

  • In 2021, the ENDO-AID product, developed by Olympus Corporation, enabled the real-time presentation of automatically discovered worrisome lesions. The EVIS X1, Olympus’ most advanced endoscopic system to date, and ENDO-AID, are compatible.

Key Segments in Capsule Endoscope Systems Industry Research

  • By Product :

    • Small Bowel Capsules
    • Esophageal Capsules
    • Colon Capsules
  • By Application :

    • OGIB (Obscure Gastrointestinal Bleeding)
    • Crohn’s Disease
    • Small Intestine Tumor
    • Others
  • By End User :

    • Hospitals
    • Ambulatory Surgery Centers
    • Others
  • By Region :

    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

Leave a Reply

Related Posts